(2021) A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm. Internal and Emergency Medicine. pp. 2181-2191. ISSN 1828-0447

(2016) Preparation and In Vitro Evaluation of Antitumor Activity of TGF alpha L3-SEB as a Ligand-Targeted Superantigen. Technology in Cancer Research & Treatment. pp. 215-226. ISSN 1533-0346

(2016) Tagging staphylococcal enterotoxin B (SEB) with TGFaL3 for breast cancer therapy. Tumor Biology. pp. 5305-5316. ISSN 1010-4283

(2014) In Silico Design and Analysis of TGFalphaL3-SEB Fusion Protein as "a New Antitumor Agent" Candidate by Ligand-Targeted Superantigens Technique. Iran J Cancer Prev. pp. 152-64. ISSN 2008-2398 (Print) 2008-2398